Lack of a requirement for a maternal humoral immune response to establish or maintain successful allogeneic pregnancy.
In general, breeding pairs are not major histocompatibility complex (MHC)-compatible, and therefore the fetoplacental unit can be considered as a natural allograft. In many mammals pregnancy leads to the production of nonlytic antibodies of antipaternal MHC specificity. It has been suggested that these protect the semiallogeneic fetus from rejection by acting as blocking or enhancing factors--or, alternatively, that they are part of a humoral response involved in the establishment of normal pregnancy. These hypotheses were tested in allomated mice made B cell deficient by continuous treatment with alpha IgM mu antiserum. The status of the maternal immune system was assessed by in vivo antibody production, in vitro mitogen responses, and allograft rejection. By these criteria B cell function could not be demonstrated in alpha IgM mu treated female mice, but T cell responses were unaffected. Allogeneic pregnancy, however, was not compromised by this humoral immune system dysfunction--litter size and neonatal survival being the same in the alpha IgM mu and control serum-treated groups. These results indicate that a maternal humoral immune response is not essential for the establishment of pregnancy or the survival of the semiallogeneic fetus.
D000361:Agammaglobulinemia / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology; D005260:Female; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D008212:Lymphocyte Depletion; D008297:Male; D051379:Mice; D011247:Pregnancy; D011270:Pregnancy, Animal; D014184:Transplantation, Homologous